ETHZilla has undergone a significant transformation, transitioning from its previous life sciences focus to become an Ethereum reserve platform. The company, now listed on Nasdaq under ‘ETHZ’ for common stock and ‘ETHZW’ for public warrants, is committed to building a community-driven platform. The rebranding effort comes following a substantial investment of $425 million through a private investment in public equity (PIPE) and a $156.25 million convertible note issuance, which allowed the company to acquire 94,675 ETH at an average price of $3,902.20 per ETH, currently valued at approximately $419 million. In addition, ETHZilla holds around $187 million in cash equivalents.